I am working in the department of Pathology, Xiangya Hospital, Central South University. My researches focus on the molecular targeted therapy for human cancers, which mainly involving: 1) Exploring the regulatory mechanism of RNA modification in cancers; 2) The role of Hippo/YAP signaling pathway in targeted therapy of cancers; 3) Searching the novel biomarkers and drug targets for the early diagnosis and therapy of cancers; 4) Clinical application of mRNA vaccine in cancers. As the first author or corresponding author, I have published 52 scientific articles in well-known SCI-indexed journals in the latest five years, such as, Journal of Hematology & Oncology (IF=40.4), Molecular Cancer (IF=33.9), Advanced Science (IF=14.1), Theranostics (IF=13.3), and Cancer letters (IF=10.1), etc. Furthermore, I am appointed as the Associate Editor of European Journal of Medical Research (SCI, JCR Q2) and Technol Cancer Res Treat (SCI, JCR Q2), meanwhile, acted as the Editorial Board member of BMC cancer and Oncology Research, and the contractual reviewer of oncology journals such as Advanced Science, Molecular therapy, and Cancer Treat Rev, etc.